Aterixen

N/A

Report date: 2026/02/26 20:00:22
NME

Base Information

Drug NameAterixen
Drug Alias NameXC-221XC-221GI
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Virus DiseasesInfluenza, Human +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPharmenterprises Llc
China Registration ClassN/A

Develop Information

Inactive CompaniesPharmenterprises Llc
Active IndicationsCoronavirus Disease 2019 (COVID-19)Virus DiseasesInfluenza, Human +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A